
Gelesis Investor Relations Material
Latest events

Q4 2022
Gelesis
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Gelesis Holdings Inc
Access all reports
Gelesis Holdings Inc. is a biotechnology company focused on developing products for weight management and metabolic health. The company creates therapeutics designed to treat obesity and other related conditions using hydrogel technology. Gelesis’ products are intended to aid in weight loss by creating a sensation of fullness, and they are based on its proprietary biomaterials platform. The company’s offerings target individuals seeking weight management solutions and those at risk of obesity-related health issues. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NYSE.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
GLS
Country
🇺🇸 United States